RAPS: EMA and FDA Begin Collaborations on Patient Engagement
30.06.2016
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) on Wednesday began exchanging more information on the best practices of involving patients in the development, evaluation and post-authorization tracking of medicines.
SciencePharma
